*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Dapagliflozin Propanediol Hydrate is a stable crystalline intermediate for SGLT2 inhibitors. It features enhanced solubility and bioavailability compared to free base forms. The compound is synthesized via controlled hydration of dapagliflozin with 1,3-propanediol.</p>
<strong>Molecular Formula:</strong> C<sub>25</sub>H<sub>34</sub>NaO<sub>9</sub>·C<sub>3</sub>H<sub>8</sub>O·H<sub>2</sub>O<br>
<strong>CAS No:</strong> 1360300-76-2
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Primary API precursor for Type 2 Diabetes treatment formulations.</li>
<li><strong>Research & Development:</strong> Standard reference material for pharmacokinetic stability studies.</li>
<li><strong>Formulation Science:</strong> Utilized in solid dispersion technologies to improve dissolution rates.</li>
</ul>
<h3>Precautions</h3>
<p>Store in sealed containers at 2°C–8°C to prevent hydrate loss. Handle with PPE in well-ventilated areas; avoid inhalation of dust. Not approved for direct human consumption without further processing.</p>